To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.

Malignant Hyperthermia Investigation Unit


Malignant Hyperthermia Investigation Unit
323-200 Elizabeth Street
Toronto Ontario, M5G 2C4 Canada





Email Address

[email protected]


The Malignant Hyperthermia Investigation Unit is dedicated to studying and reducing complications associated with malignant hyperthermia. This is a hereditary disorder in which a person does not react appropriately to certain drugs (e.g., anesthetics) due to a genetic abnormality. Founded in 1976, the association has three main objectives: education, communication, and research. It provides financial support to current test standardization and genetic and lymphocyte research. In addition, the organization also produces educational materials of interest to the general public and medical professionals.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.